Welcome to LookChem.com Sign In|Join Free
  • or
N-(2-(2-(2-(2-(2-(2-trityloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyloleoylamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1046804-96-9

Post Buying Request

1046804-96-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1046804-96-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1046804-96-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,8,0 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1046804-96:
(9*1)+(8*0)+(7*4)+(6*6)+(5*8)+(4*0)+(3*4)+(2*9)+(1*6)=149
149 % 10 = 9
So 1046804-96-9 is a valid CAS Registry Number.

1046804-96-9Relevant academic research and scientific papers

THE TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER EFFECT

-

Page/Page column 17, (2009/12/07)

The present invention provides aminoside tetracyclic anthraquinones represented by formula (I) or formula (II), wherein the piptides are introduced to connect tetracyclic anthraquinones and fatty acid saturated or unsaturated in order to make the anticancer agents to be absorbed and released selectively; meanwhile some water-solubility groups are also introduced into the branched chain, aminosaccharide and tetracyclic moiety of the compounds to improve the water-solubility. The present invention also provides the preparative method and the use thereof as pharmaceutically active components for treating the diseases cured by aminoside tetracyclic anthraquinone, for example cancer, such as intestines, liver, gastric, breast, lung, ovary, prostate, brain glioma, lymph, skin, pigment, thyroid gland, multiple bone marrow cancer and leukemia.

TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER PROPERTIES

-

Page/Page column 11, (2010/01/31)

The present invention provides aminoside tetracyclic anthraquinones represented by formula (I) or formula (II), wherein the peptides are introduced to connect tetracyclic anthraquinones and fatty acid saturated or unsaturated in order to make the anticancer agents to be absorbed and released selectively; meanwhile some water-solubility groups are also introduced into the branched chain, aminosaccharide and tetracyclic moiety of the compounds to improve the water-solubility. The present invention also provides the preparative method and the use thereof as pharmaceutically active components for treating the diseases cured by aminoside tetracyclic anthraquinone, for example cancer, such as intestines, liver, gastric, breast, lung, ovary, prostate, brain glioma, lymph, skin, pigment, thyroid gland, multiple bone marrow cancer and leukemia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1046804-96-9